Good Morning, It’s Monday January 9th, 2012, I’m Christina Collins with CRWENewswire Stocks In Action. On its first quarter fiscal 2012, Acuity Brands Incorporated - symbol AYI - posted net sales of $474.3 million, an approximately 12 percent increase year over year. According to a definitive agreement between the companies, Bristol-Myers Squibb will acquire Inhibitex Incorporated - symbol INHX - for $26.00 per share in cash pursuant to a cash tender offer and second step merger, and lastly Idenix Pharmaceuticals Incorporated - symbol IDIX - provided interim data from a 12-week phase IIb clinical trial of IDX184, its lead product candidate for the treatment of hepatitis C virus infection. According to the compoany, IDX184 has demonstrated a high barrier to resistance in vitro and potent antiviral activity in both preclinical and clinical studies. Thank you for joining me and have a great week! For CRWE Newswire, Stocks In Action, I’m Christina Collins.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. crwenewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (Read more at http://www.crwenewswire.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold crwenewswire.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.